Sergio Giralt Selected Research

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)

3/2024	A multicenter study of posttransplantation low-dose inotuzumab ozogamicin to prevent relapse of acute lymphoblastic leukemia.
1/2021	Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells.
11/2020	Hematopoietic recovery in patients receiving chimeric antigen receptor T-cell therapy for hematologic malignancies.
1/2020	Comparing CAR T-cell toxicity grading systems: application of the ASTCT grading system and implications for management.
2/2014	Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia.
2/2013	T cell-depleted stem cell transplantation for adults with high-risk acute lymphoblastic leukemia: long-term survival for patients in first complete remission with a decreased risk of graft-versus-host disease.
4/2012	Long-term follow-up of allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: impact of tyrosine kinase inhibitors on treatment outcomes.
2/2009	Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies.
8/2006	Allogeneic stem cell transplantation for patients with chronic myeloid leukemia and acute lymphocytic leukemia after Bcr-Abl kinase mutation-related imatinib failure.
5/2003	Allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning in acute lymphoblastic leukemia: a feasibility study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sergio Giralt Research Topics

Disease

77	Multiple Myeloma 05/2024 - 09/2003
46	Neoplasms (Cancer) 04/2024 - 01/2002
41	Graft vs Host Disease (Graft-Versus-Host Disease) 03/2024 - 01/2002
32	Hematologic Neoplasms (Hematological Malignancy) 03/2024 - 01/2002
32	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2021 - 08/2004
26	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2021 - 01/2002
15	Leukemia 01/2022 - 01/2002
13	Infections 02/2024 - 02/2009
12	Disease Progression 03/2024 - 06/2004
12	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2015 - 01/2000
11	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2024 - 01/2002
11	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2023 - 06/2004
11	Lymphoma (Lymphomas) 01/2021 - 06/2004
7	Bronchiolitis Obliterans Syndrome 01/2022 - 03/2004
6	Residual Neoplasm 05/2024 - 09/2010
6	Neutropenia 02/2024 - 10/2011
5	Cytokine Release Syndrome 03/2023 - 02/2014
5	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2022 - 02/2010
4	Agammaglobulinemia (Hypogammaglobulinemia) 02/2024 - 01/2023
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021 - 05/2003
4	Pain (Aches) 01/2020 - 04/2007
3	Cytopenia 01/2023 - 11/2020
3	Viremia 01/2023 - 10/2011
3	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023 - 11/2020
3	Plasma Cell Leukemia 01/2023 - 10/2006
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 04/2006 - 01/2004
2	Abdominal Obesity 01/2024 - 09/2023
2	Primary Myelofibrosis (Myelosclerosis) 01/2023 - 04/2010
2	cell-associated neurotoxicity 01/2021 - 01/2020
2	Pathologic Complete Response 11/2020 - 08/2004
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 04/2016 - 06/2008

Drug/Important Bio-Agent (IBA)

20	Melphalan (Alkeran)FDA LinkGeneric 12/2020 - 05/2003
15	Lenalidomide (CC 5013)FDA Link 05/2024 - 10/2007
12	Tacrolimus (Prograf)FDA LinkGeneric 01/2022 - 03/2003
11	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 05/2003
10	Chimeric Antigen ReceptorsIBA 03/2024 - 02/2014
10	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2023 - 03/2003
10	Rituximab (Mabthera)FDA Link 01/2020 - 04/2003
9	Dexamethasone (Maxidex)FDA LinkGeneric 03/2024 - 06/2011
9	trans-crotonin (CTN)IBA 02/2024 - 12/2011
9	fludarabineIBA 01/2020 - 08/2004
7	Bortezomib (Velcade)FDA Link 03/2024 - 04/2007
6	Busulfan (Busulfex)FDA Link 01/2020 - 03/2003
6	Tyrosine Kinase InhibitorsIBA 04/2012 - 03/2007
6	Imatinib Mesylate (Gleevec)FDA Link 03/2011 - 01/2000
5	B-Cell Maturation AntigenIBA 04/2024 - 11/2020
5	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 09/2003
5	Proteasome InhibitorsIBA 03/2024 - 01/2020
5	Alemtuzumab (Campath)FDA Link 12/2014 - 05/2003
4	ixazomibIBA 03/2024 - 01/2020
4	Monoclonal AntibodiesIBA 11/2023 - 07/2006
4	Phosphotransferases (Kinase)IBA 01/2023 - 08/2006
4	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2017 - 01/2002
4	Cyclosporine (Ciclosporin)FDA LinkGeneric 12/2014 - 08/2005
4	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2014 - 04/2003
4	SteroidsIBA 12/2009 - 06/2004
3	idecabtagene vicleucelIBA 04/2024 - 03/2023
3	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 04/2024 - 01/2023
3	daratumumabIBA 03/2024 - 03/2023
3	carfilzomibIBA 03/2024 - 02/2023
3	salicylhydroxamic acid (SHAM)IBA 12/2023 - 01/2018
3	Anti-Bacterial Agents (Antibiotics)IBA 10/2023 - 01/2016
3	Antiviral Agents (Antivirals)IBA 01/2023 - 01/2019
3	Calcineurin InhibitorsIBA 01/2022 - 11/2012
3	CytokinesIBA 11/2021 - 06/2009
3	tisagenlecleucelIBA 01/2021 - 01/2020
3	axicabtagene ciloleucelIBA 01/2021 - 01/2020
3	Azacitidine (5 Azacytidine)FDA Link 11/2020 - 05/2009
3	Etoposide (VP 16)FDA LinkGeneric 10/2015 - 05/2003
3	Mycophenolic Acid (Cellcept)FDA LinkGeneric 05/2015 - 05/2013
3	Cytarabine (Cytosar-U)FDA LinkGeneric 04/2014 - 01/2002
3	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 06/2013 - 06/2004
3	HLA Antigens (Human Leukocyte Antigens)IBA 03/2013 - 03/2007
3	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 10/2011 - 06/2004
2	Heme (Haem)IBA 03/2024 - 10/2023
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2023 - 06/2011
2	AntibodiesIBA 11/2023 - 05/2014
2	Immunomodulating AgentsIBA 03/2023 - 01/2020
2	Alkylating AgentsIBA 01/2023 - 04/2003
2	FluoroquinolonesIBA 12/2021 - 10/2014
2	Decitabine FDA Link 01/2021 - 03/2003
2	Ferritins (Ferritin)IBA 11/2020 - 01/2009
2	Surface Antigens (Surface Antigen)IBA 11/2019 - 05/2010
2	defibrotideIBA 03/2016 - 08/2012
2	VaccinesIBA 12/2015 - 08/2010
2	Ifosfamide FDA LinkGeneric 10/2015 - 06/2011

Therapy/Procedure

63	Hematopoietic Stem Cell Transplantation 10/2023 - 01/2003
61	Therapeutics 04/2024 - 01/2003
49	Transplantation 03/2024 - 01/2002
48	Stem Cell Transplantation 09/2023 - 01/2002
36	Cell Transplantation 05/2024 - 12/2007
25	Drug Therapy (Chemotherapy) 12/2023 - 01/2002
15	Homologous Transplantation 01/2023 - 01/2002
6	Autologous Transplantation 01/2019 - 06/2004
6	Hematopoietic Stem Cell Mobilization 01/2017 - 07/2006
5	Salvage Therapy 01/2023 - 06/2004
5	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 06/2011 - 01/2002
4	Immunotherapy 11/2023 - 08/2010
3	Radiotherapy 01/2020 - 05/2007
3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 09/2005 - 01/2002